GlaxoSmithKline plc (GSK.L)


LSE - LSE Delayed Price. Currency in GBp
1,643.00-4.50 (-0.27%)
At close: 12:06 PM EDT
People also watch:
BP.LAZN.LRDSB.LVOD.LULVR.L
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1,645.00
Prev Close1,647.50
Bid1,628.50 x 175400
Ask1,650.00 x 417900
Day's Range1,625.85 - 1,645.00
52wk Range1,277.25 - 1,716.50
1y Target EstN/A
Market Cap79.62B
P/E Ratio (ttm)2,738.33
BetaN/A
Volume9,331,494
Avg Vol (3m)7,757,982
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Associated Press8 hours ago

    Glaxo paying $20M to resolve SEC charges of China bribery

    WASHINGTON (AP) — GlaxoSmithKline PLC has agreed to pay $20 million to resolve U.S. regulators' allegations that the pharmaceutical giant's China operations bribed officials to boost drug sales.

  • The Wall Street Journal10 hours ago

    [$$] GlaxoSmithKline to Pay $20 Million to Settle SEC Bribery Probe

    GlaxoSmithKline PLC agreed to pay $20 million to settle charges that the drugmaker’s Chinese subsidiaries engaged in bribery schemes to increase sales in the Asian country, the Securities and Exchange ...

  • Reuters12 hours ago

    GlaxoSmithKline to pay $20 mln to settle U.S. foreign bribery case

    GlaxoSmithKline Plc will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses, U.S. regulators said on Friday. The pharmaceutical company agreed to settle the case with the Securities and Exchange Commission without admitting or denying any wrongdoing. In a statement, the company said it had cooperated with the SEC and it had received credit for taking steps to improve its operations, such as changing how sales representatives are paid and stopping the practice of paying healthcare professionals to speak to doctors about the company's products.